Altimmune, Inc.
(NASDAQ : ALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 5.69%129.007.9%$454.78m
CHGGChegg, Inc. 3.07%76.7915.3%$255.75m
ADTADT, Inc. -1.09%11.811.4%$146.29m
FLTFleetCor Technologies, Inc. 1.75%234.613.5%$142.47m
CPRTCopart, Inc. 0.27%100.254.4%$137.85m
EFXEquifax, Inc. -0.02%166.832.0%$134.34m
MARAMarathon Patent Group, Inc. 1.47%3.621.5%$124.98m
CDAYCeridian HCM Holding, Inc. 3.76%72.530.0%$115.59m
STMPStamps.com, Inc. 3.85%276.7725.7%$113.71m
BAHBooz Allen Hamilton Holding Corp. 0.59%85.912.0%$82.76m
CRLCharles River Laboratories International, Inc. -1.00%217.464.5%$82.50m
BOXLBoxlight Corp. -11.85%2.200.0%$81.31m
ALTAltimmune, Inc. 6.01%23.940.0%$79.93m
BRBroadridge Financial Solutions, Inc. -0.22%138.811.5%$73.54m
BFAMBright Horizons Family Solutions, Inc. 1.71%128.161.5%$72.89m

Company Profile

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.